September 17th 2025
A study found that recommended treatment significantly increases survival rates in women aged 65 years and older with early-stage cervical cancer.
September 17th 2025
September 12th 2025
Timely surveillance reported in under half of HPV-positive patients
January 20th 2025A recent study highlights gaps in cervical cancer screening compliance, with fewer than 50% of human papillomavirus-positive, negative for intraepithelial lesion or malignancy patients receiving recommended follow-up testing within the guideline time frame.
Read More
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities
December 17th 2024A quality improvement project highlights the benefits of starting human papillomavirus vaccination at age 9 years to increase uptake and reduce disparities in cancer prevention across pediatric populations.
Watch
Reduced cost-effectiveness reported from HPV vaccination in mid-adults
November 27th 2024A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.
Read More